A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.
DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years ...
BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience innovator specializing in ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...
Laxxon Medical, a leading pharmaceutical technology company, pioneering a new generation of advanced oral drug delivery systems, today announced that it will be attending BIO-Europe 2025 and the ...
Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...
Pancreatic ductal adenocarcinoma (PDAC), the most prevalent subtype of pancreatic cancer, constitutes approximately 90% of all pancreatic cancer cases. It is recognized as one of the most aggressive ...
HANGZHOU, China, Oct. 9, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback